{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:47:53Z","timestamp":1783572473959,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2019-06749"],"award-info":[{"award-number":["RGPIN-2019-06749"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jinorgbio.2025.113088","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:35Z","timestamp":1759336355000},"page":"113088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of dual-function molecules containing both Zn-Ionophore and aggregation inhibition moieties for mutant p53 protein reactivation"],"prefix":"10.1016","volume":"274","author":[{"given":"Kalvin","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauryn","family":"Grcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo L.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Castro-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Orvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mellitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gaiddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cellsig.2017.02.005","article-title":"Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression","volume":"33","author":"Lazo","year":"2017","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.jinorgbio.2025.113088_bb0015","doi-asserted-by":"crossref","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"p53 research: the past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.jinorgbio.2025.113088_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.jinorgbio.2025.113088_bb0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"6381","key":"10.1016\/j.jinorgbio.2025.113088_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.jinorgbio.2025.113088_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1389450114666140106101412","article-title":"Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities","volume":"15","author":"Bo","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0050","first-page":"89","article-title":"Targeting mutant p53 for efficient cancer therapy","author":"Bykov","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.jinorgbio.2025.113088_bb0055","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/cancers15102834","article-title":"Metal-based anticancer Complexes and p53: how much do we know?","volume":"15","author":"Alfadul","year":"2023","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.jinorgbio.2025.113088_bb0060","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41388-018-0652-y","article-title":"Cancer therapeutic targeting using mutant\u2013p53-specific siRNAs","volume":"38","author":"Ubby","year":"2019","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.jinorgbio.2025.113088_bb0065","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1039\/D0CS00163E","article-title":"A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer","volume":"49","author":"Miller","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.jinorgbio.2025.113088_bb0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/biom10040635","article-title":"Recent synthetic approaches towards small molecule reactivators of p53","volume":"10","author":"Silva","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.jinorgbio.2025.113088_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/biom10020303","article-title":"Follow the mutations: toward class-specific, small-molecule reactivation of p53","volume":"10","author":"Loh","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.jinorgbio.2025.113088_bb0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10495-014-0990-3","article-title":"Small molecule compounds targeting the p53 pathway: are we finally making progress?","volume":"19","author":"Yu","year":"2014","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0085","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1039\/D3CC05834D","article-title":"Targeting misfolding and aggregation of the amyloid-\u03b2 peptide and mutant p53 protein using multifunctional molecules","volume":"60","author":"Grcic","year":"2024","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why are there hotspot mutations in the TP53 gene in human cancers?","volume":"25","author":"Baugh","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0095","doi-asserted-by":"crossref","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61487","article-title":"Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants","volume":"9","author":"Blanden","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102230","article-title":"Inhibition of p53 protein aggregation as a cancer treatment strategy","volume":"72","author":"Kwan","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"67","key":"10.1016\/j.jinorgbio.2025.113088_bb0110","doi-asserted-by":"crossref","first-page":"17734","DOI":"10.1002\/chem.201802677","article-title":"Multifunctional compounds for activation of the p53-Y220C mutant in Cancer","volume":"24","author":"Miller","year":"2018","journal-title":"Chem. Eur. J."},{"issue":"5","key":"10.1016\/j.jinorgbio.2025.113088_bb0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1124\/mol.114.097550","article-title":"Synthetic Metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an Ionophore","volume":"87","author":"Blanden","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.drudis.2015.07.006","article-title":"Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer","volume":"20","author":"Blanden","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.jinorgbio.2025.113088_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/mol.116.107409","article-title":"Thiosemicarbazones functioning as zinc Metallochaperones to reactivate mutant p53","volume":"91","author":"Yu","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0130","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.18632\/oncotarget.2432","article-title":"Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism","volume":"5","author":"Yu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/onci.26198","article-title":"Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells","volume":"2","author":"Cirone","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0140","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2015.3125","article-title":"Zn(II)-curc targets p53 in thyroid cancer cells","volume":"47","author":"Garufi","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.217","article-title":"Degradation of mutant p53H175 protein by Zn(II) through autophagy","volume":"5","author":"Garufi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.jinorgbio.2025.113088_bb0150","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acs.jmedchem.0c01360","article-title":"Benzothiazolyl and Benzoxazolyl Hydrazones function as zinc Metallochaperones to reactivate mutant p53","volume":"64","author":"Gilleran","year":"2021","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.jinorgbio.2025.113088_bb0155","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-18-0822","article-title":"Zinc Metallochaperones reactivate mutant p53 using an ON\/OFF switch mechanism: a new paradigm in cancer therapeutics","volume":"24","author":"Yu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"6586","key":"10.1016\/j.jinorgbio.2025.113088_bb0160","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"Supplement C","key":"10.1016\/j.jinorgbio.2025.113088_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbpa.2016.12.011","article-title":"Developing drugs targeting transition metal homeostasis","volume":"37","author":"Weekley","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"10","key":"10.1016\/j.jinorgbio.2025.113088_bb0170","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1021\/acs.jmedchem.6b00238","article-title":"Zinc(II)\u2013Thiosemicarbazone Complexes are localized to the lysosomal compartment where they Transmetallate with copper ions to induce cytotoxicity","volume":"59","author":"Stacy","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166164","article-title":"Intracellular Iron chelation modulates the macrophage Iron phenotype with consequences on tumor progression","volume":"11","author":"Mertens","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinorgbio.2025.113088_bb0180","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C6MT00105J","article-title":"Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics","volume":"8","author":"Park","year":"2016","journal-title":"Metallomics"},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0185","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1021\/acs.inorgchem.7b00710","article-title":"Bis(thiosemicarbazone) Complexes of cobalt(III). Synthesis, characterization, and anticancer potential","volume":"56","author":"King","year":"2017","journal-title":"Inorg. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2025.113088_bb0190","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acs.bioconjchem.6b00332","article-title":"Targeting iron in colon cancer via Glycoconjugation of Thiosemicarbazone Prochelators","volume":"27","author":"Akam","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"28","key":"10.1016\/j.jinorgbio.2025.113088_bb0195","doi-asserted-by":"crossref","first-page":"15197","DOI":"10.1021\/jacs.3c02033","article-title":"Design of Tetrazolium Cations for the release of Antiproliferative formazan chelators in mammalian cells","volume":"145","author":"Xu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112433","article-title":"Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation","volume":"251","author":"Kwan","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0205","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-18-1080","article-title":"Combinatorial therapy of zinc metallochaperones with mutant p53 reactivation and diminished copper binding","volume":"18","author":"Zaman","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112164","article-title":"Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C","volume":"242","author":"Miller","year":"2023","journal-title":"J. Inorg. Biochem."},{"issue":"46","key":"10.1016\/j.jinorgbio.2025.113088_bb0215","doi-asserted-by":"crossref","first-page":"10802","DOI":"10.1039\/C9SC04151F","article-title":"Bifunctional ligand design for modulating mutant p53 aggregation in cancer","volume":"10","author":"Miller","year":"2019","journal-title":"Chem. Sci."},{"issue":"0","key":"10.1016\/j.jinorgbio.2025.113088_bb0220","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1039\/jr9340001305","article-title":"282. Reactions between hexamethylenetetramine and phenolic compounds. Part II. Formation of phenolic aldehydes. Distinctive behaviour of p-nitrophenol","author":"Duff","year":"1934","journal-title":"J. Chem. Soc."},{"issue":"24","key":"10.1016\/j.jinorgbio.2025.113088_bb0225","doi-asserted-by":"crossref","first-page":"16353","DOI":"10.1021\/acs.jmedchem.2c01174","article-title":"Potent ruthenium-ferrocene bimetallic antitumor antiangiogenic agent That circumvents platinum resistance: from synthesis and mechanistic studies to in vivo evaluation in zebrafish","volume":"65","author":"Manikandan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.jinorgbio.2025.113088_bb0230","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1021\/acs.inorgchem.6b00359","article-title":"CF3 derivatives of the anticancer Ru(III) Complexes KP1019, NKP-1339, and their imidazole and pyridine analogues show enhanced lipophilicity, albumin interactions, and cytotoxicity","volume":"55","author":"Chang","year":"2016","journal-title":"Inorg. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2025.113088_bb0235","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/bi026635n","article-title":"Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain","volume":"42","author":"Butler","year":"2003","journal-title":"Biochemistry"},{"issue":"26","key":"10.1016\/j.jinorgbio.2025.113088_bb0240","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1073\/pnas.94.26.14338","article-title":"Thermodynamic stability of wild-type and mutant p53 core domain","volume":"94","author":"Bullock","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.jinorgbio.2025.113088_bb0245","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1139\/v74-261","article-title":"Stability of some metal-COMPLEXES in mixed solvents","volume":"52","author":"Mui","year":"1974","journal-title":"Can. J. Chem."},{"issue":"49","key":"10.1016\/j.jinorgbio.2025.113088_bb0250","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1021\/ja992709f","article-title":"Aqueous coordination chemistry of quinoline-based fluorescence probes for the biological chemistry of zinc","volume":"121","author":"Fahrni","year":"1999","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"10.1016\/j.jinorgbio.2025.113088_bb0255","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1021\/ic901662z","article-title":"Structures, metal ion affinities, and fluorescence properties of soluble derivatives of Tris((6-phenyl-2-pyridyl)methyl)amine","volume":"48","author":"Liang","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jct.2017.05.003","article-title":"The impact of mixed solvents on the complexation thermodynamics of Eu(III) by simple carboxylate and amino carboxylate ligands","volume":"114","author":"Felmy","year":"2017","journal-title":"J. Chem. Thermodyn."},{"issue":"23","key":"10.1016\/j.jinorgbio.2025.113088_bb0265","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between inhibition constant (K1) and concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic-reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20134","key":"10.1016\/j.jinorgbio.2025.113088_bb0270","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10799898809049010","article-title":"An exact correction to the cheng-prusoff correction","volume":"8","author":"Munson","year":"1988","journal-title":"J. Recept. Res."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Malmos","year":"2017","journal-title":"Amyloid"},{"issue":"7","key":"10.1016\/j.jinorgbio.2025.113088_bb0280","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta Proteins Proteomics."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccell.2015.12.002","article-title":"A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas","volume":"29","author":"Soragni","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0290","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41467-021-23985-1","article-title":"Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function","volume":"12","author":"Palanikumar","year":"2021","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.jinorgbio.2025.113088_bb0295","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.3390\/ijms231911023","article-title":"Anticancer therapeutic strategies targeting p53 aggregation","volume":"23","author":"Ferretti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40164-022-00317-7","article-title":"p53 amyloid aggregation in cancer: function, mechanism, and therapy","volume":"11","author":"Li","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1039\/C4MT00252K","article-title":"Modulation of the a[small beta] peptide aggregation pathway by KP1019 limits a[small beta]-associated neurotoxicity","volume":"7","author":"Jones","year":"2015","journal-title":"Metallomics"},{"issue":"48","key":"10.1016\/j.jinorgbio.2025.113088_bb0310","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1021\/jp108035y","article-title":"NMR reveals two-step association of Congo red to amyloid \u03b2 in low-molecular-weight aggregates","volume":"114","author":"Pedersen","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0315","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2006.08.001","article-title":"Congo red and protein aggregation in neurodegenerative diseases","volume":"53","author":"Frid","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"18","key":"10.1016\/j.jinorgbio.2025.113088_bb0320","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/00001756-199412000-00006","article-title":"Congo-red protects against toxicity of beta-amyloid peptides on rat hippocampal-neurons","volume":"5","author":"Burgevin","year":"1994","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.jinorgbio.2025.113088_bb0325","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/cancers13040916","article-title":"Isoforms of the p53 family and gastric cancer: a m\u00e9nage \u00e0 trois for an unfinished affair","volume":"13","author":"Blanchet","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.04.035","article-title":"Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines","volume":"152","author":"Baud","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jinorgbio.2025.113088_bb0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0143-4160(02)00053-2","article-title":"Measuring zinc in living cells.: a new generation of sensitive and selective fluorescent probes","volume":"31","author":"Gee","year":"2002","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.jinorgbio.2025.113088_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100050","article-title":"Protocol for quantifying zinc flux in cultured cells using fluorescent indicators","volume":"1","author":"Ali","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0345","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.molliq.2015.08.007","article-title":"Thermodynamics of Zn2+ 2-mercaptopyridine-N-oxide and 2-hydroxypyridine-N-oxide interactions: stability, solubility, activity coefficients and medium effects","volume":"211","author":"Bretti","year":"2015","journal-title":"J. Mol. Liq."},{"issue":"13","key":"10.1016\/j.jinorgbio.2025.113088_bb0350","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/ac60219a034","article-title":"Structure and behavior of organic analytical reagents. Formation constants of transition metal complexes of 2-Hydroxypyridine-1-oxide and 2-Mercaptopyridine-1-oxide","volume":"36","author":"Sun","year":"1964","journal-title":"Anal. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2025.113088_bb0355","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.18632\/oncotarget.14572","article-title":"Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108218","article-title":"Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.jinorgbio.2025.113088_bb0365","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/acs.jmedchem.8b01996","article-title":"Novel Triapine derivative induces copper-dependent cell death in hematopoietic cancers","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.jinorgbio.2025.113088_bb0370","doi-asserted-by":"crossref","first-page":"14758","DOI":"10.1021\/jacs.2c05355","article-title":"Copper-catalyzed glutathione oxidation is accelerated by the anticancer Thiosemicarbazone Dp44mT and further boosted at lower pH","volume":"144","author":"Falcone","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.jinorgbio.2025.113088_bb0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxlet.2010.12.017","article-title":"The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress","volume":"201","author":"Myers","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"20","key":"10.1016\/j.jinorgbio.2025.113088_bb0380","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiose micarbazone","volume":"35","author":"Liu","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0385","first-page":"11","article-title":"A novel ruthenium(II) complex with Lapachol induces G2\/M phase arrest through Aurora-B kinase Down-regulation and ROS-mediated apoptosis in human prostate adenocarcinoma cells","author":"De Grandis","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11101-013-9289-1","article-title":"Lapachol and its congeners as anticancer agents: a review","volume":"13","author":"Epifano","year":"2014","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0395","series-title":"Medicinal Chemistry of Anticancer Drugs (Third Edition)","first-page":"165","article-title":"Chapter 4 - anticancer strategies involving radical species","author":"Avenda\u00f1o","year":"2023"},{"issue":"11","key":"10.1016\/j.jinorgbio.2025.113088_bb0400","article-title":"Blockade of cellular energy metabolism through 6-Aminonicotinamide reduces proliferation of non-small lung cancer cells by inducing endoplasmic reticulum stress","volume":"10","author":"Kaushik","year":"2021","journal-title":"Biology-Basel"},{"issue":"1\u20132","key":"10.1016\/j.jinorgbio.2025.113088_bb0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-5793(98)00959-4","article-title":"Inhibition of NADPH supply by 6-aminonicotinamide: effect on glutathione, nitric oxide and superoxide in J774 cells","volume":"434","author":"Hothersall","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0410","series-title":"Purification of Laboratory Chemicals","author":"Perrin","year":"1988"},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2019.108019","article-title":"Red and blue emitting fluorescent probe for cyanide and hypochlorite ions: biological sensing and environmental analysis","volume":"174","author":"Malkondu","year":"2020","journal-title":"Dyes Pigments"},{"issue":"46","key":"10.1016\/j.jinorgbio.2025.113088_bb0420","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.tetlet.2007.09.074","article-title":"A simple method for the alkaline hydrolysis of esters","volume":"48","author":"Theodorou","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"5","key":"10.1016\/j.jinorgbio.2025.113088_bb0425","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1021\/ja011774y","article-title":"Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator","volume":"124","author":"Gee","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jinorgbio.2025.113088_bb0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"12","key":"10.1016\/j.jinorgbio.2025.113088_bb0435","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/sj.cdd.4402216","article-title":"Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis","volume":"14","author":"Benosman","year":"2007","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.jinorgbio.2025.113088_bb0440","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.jinorgbio.2025.113088_bb0445","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jinorgbio.2025.113088_bb0450","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-0716-2309-1_24","article-title":"A plate reader-based measurement of the cellular ROS production using Dihydroethidium and MitoSOX","volume":"2497","author":"Chung","year":"2022","journal-title":"Methods Mol. Biol."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:30:07Z","timestamp":1780410607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013425002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":90,"alternative-id":["S0162013425002685"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113088","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dual-function molecules containing both Zn-Ionophore and aggregation inhibition moieties for mutant p53 protein reactivation","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113088"}}